Category: 1662-01-7

With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.1662-01-7,4,7-Diphenyl-1,10-phenanthroline,as a common compound, the synthetic route is as follows.

General procedure: Complexes were synthesized using the following general procedure: to an ethanolic (or methanolic) solution of glycine (1mmol) and NaOH (1mmol) salicylaldehyde (1mmol) was added. The resulting yellow solution was stirred for 30min at room temperature and a solution of Zn(CH3COO)2.2H2O (1mmol in 5mL of water) was added dropwise. The pH was adjusted to 7 with 1M NaOH and the mixture was stirred at room temperature for 1h. The polypyridyl (1mmol) in ethanol (10mL) was then added and the resulting solution stirred at room temperature for 1h, subsequently concentrated and left overnight at 4C. The precipitate obtained was filtered, washed with cold ethanol and diethyl ether and dried in vacuum., 1662-01-7

As the paragraph descriping shows that 1662-01-7 is playing an increasingly important role.

Reference£º
Article; Matos, Cristina P.; Addis, Yemataw; Nunes, Patrique; Barroso, Sonia; Alho, Irina; Martins, Marta; Matos, Antonio P.A.; Marques, Fernanda; Cavaco, Isabel; Costa Pessoa, Joao; Correia, Isabel; Journal of Inorganic Biochemistry; vol. 198; (2019);,
Metal catalyst and ligand design
Ligand Template Strategies for Catalyst Encapsulation – NCBI

1662-01-7, 4,7-Diphenyl-1,10-phenanthroline is a catalyst-ligand compound, ?involved in a variety of chemical synthesis. Rlated chemical reaction is continuously updated

The complex was prepared by a general synthetic method in which a mixture of bphen (1 mmol) andcopper(II) nitrate trihydrate (1 mmol) in 20 mL methanol was added dropwise to an aqueous solution(10 mL) of leu (1 mmol) and KOH (1 mmol) with stirring for about 20 min. The resulting solution wasleft to evaporate slowly at room temperature. After 6 days, dark green crystals were obtained. Yieldwas 83%. Anal. Calcd for C30H30CuN4O6 (606.12 g mol-1) (%): C, 59.45; H, 4.99; N, 9.24. Found: C, 59.37;H, 4.89; N, 9.18.

1662-01-7, As the paragraph descriping shows that 1662-01-7 is playing an increasingly important role.

Reference£º
Article; Inci, Duygu; Aydin, Rahmiye; Zorlu, Yunus; Journal of Coordination Chemistry; vol. 69; 18; (2016); p. 2677 – 2696;,
Metal catalyst and ligand design
Ligand Template Strategies for Catalyst Encapsulation – NCBI

With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.1662-01-7,4,7-Diphenyl-1,10-phenanthroline,as a common compound, the synthetic route is as follows.

A solution of (No.5-Ind) Mo (CO) 2 (3-C3H5) (0.20g, 0.65 mmol) in CH2C12 was treated with HBF4. Et2O (1 eq. ). After 10 minutes dme was added in excess and the reaction was left for 15 minutes. 0.27 g (0.8 mmol) of 4, 7-diphenil-1, 10-phenantroline were added and the reaction was left for 2 hours at room temperature. After concentration to about 5 ml and addition of Et20, a ruby complex precipitated. The mixture was filtered and the residue recrystallized from CH2CI2/Et2O (razz 90%). A drawing of the structure and physical data are given in Table 1., 1662-01-7

The synthetic route of 1662-01-7 has been constantly updated, and we look forward to future research findings.

Reference£º
Patent; IBET-INSTITUTO DE BIOLOGIA EXPERIMENTAL E TECNOLOGICA; WO2005/87783; (2005); A1;,
Metal catalyst and ligand design
Ligand Template Strategies for Catalyst Encapsulation – NCBI

1662-01-7, 4,7-Diphenyl-1,10-phenanthroline is a catalyst-ligand compound, ?involved in a variety of chemical synthesis. Rlated chemical reaction is continuously updated,1662-01-7

General procedure: A mixture of CuBr (28.7mg, 0.2mmol) and dppp (82.5mg, 0.2mmol) with an excess of batho (66.5mg, 0.2mmol) were dissolved in CH2Cl2 (5mL) and CH3OH (5mL) solution, stirred at room temperature for 6h. The insoluble residues were removed by filtration, and the filtrate was evaporated slowly at room temperature to yield yellow crystalline products.

As the paragraph descriping shows that 1662-01-7 is playing an increasingly important role.

Reference£º
Article; Yu, Xiao; Fan, Weiwei; Wang, Guo; Lin, Sen; Li, Zhongfeng; Liu, Min; Yang, Yuping; Xin, Xiulan; Jin, Qionghua; Polyhedron; vol. 157; (2019); p. 301 – 309;,
Metal catalyst and ligand design
Ligand Template Strategies for Catalyst Encapsulation – NCBI

With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.1662-01-7,4,7-Diphenyl-1,10-phenanthroline,as a common compound, the synthetic route is as follows.

The [Ru(dpphen)3]Cl2 is synthesized using literature method [35] . RuCl3?3H2O (1 mmol) and 4,7-diphen-1,10-phenanthroline (3 mmol) is taken in ethylene glycol under nitrogen atmosphere and heated to reflux for 72 h and the crude product is chromatographed using silica gel. The solution on evaporation yielded orange red crystals. Yield = 85% ESI-MS (m/z) 548.6496 (M-2Cl- doubly charged species)., 1662-01-7

As the paragraph descriping shows that 1662-01-7 is playing an increasingly important role.

Reference£º
Article; Babu, Eththilu; Muthu Mareeswaran, Paulpandian; Singaravadivel, Subramanian; Bhuvaneswari, Jayaraman; Rajagopal, Seenivasan; Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy; vol. 130; (2014); p. 553 – 560;,
Metal catalyst and ligand design
Ligand Template Strategies for Catalyst Encapsulation – NCBI

With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.1662-01-7,4,7-Diphenyl-1,10-phenanthroline,as a common compound, the synthetic route is as follows.

A solution of 4,7-diphenyl-1,10-phenanthroline (0.36 g, 1.10 mmol) in methanol (10 ml) was added to a solution of TlCl3*4H2O (0.42 g, 1.10 mmol) in methanol (10 ml) and the resulting colorless solution was stirred for 20 min at 40C. Suitable crystals for the X-ray diffraction measurement were obtained by methanol diffusion to a colorless solution of 1 in DMSO over two weeks (yield 0.60 g, 75.6%, m.p. > 300C). IR (CsI, cm-1): 3060 m, 2921 m, 2854 w, 1611 m, 1563 m, 1510 m, 1433 s, 1365 s, 1275 w, 1234 m, 1098 m, 1010 s, 941 m, 849 s, 759 s, 700 s, 626 w, 554 m, 491 w, 420 m, 339 m, 262 m. UV-Vis: lambdamax (DMSO, nm), 315. Anal. calcd. (%): C 43.29, H 3.05, N 3.88. Found (%): C 43.01, H 3.03, N 3.85.

The synthetic route of 1662-01-7 has been constantly updated, and we look forward to future research findings.

Reference£º
Article; Ghadermazi; Journal of Structural Chemistry; vol. 57; 5; (2016); p. 970 – 975; Zh. Strukt. Kim.; vol. 57; 5; (2016); p. 1020 – 1025,6;,
Metal catalyst and ligand design
Ligand Template Strategies for Catalyst Encapsulation – NCBI

With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.1662-01-7,4,7-Diphenyl-1,10-phenanthroline,as a common compound, the synthetic route is as follows.

The complex was synthesized by adapting to literature methods7, 14 of an analogous compound.[Ru(benzene)Cl2]2 (0.75g, 1.5 mmol) and 4,7-diphenyl-1,10-phenanthroline (1.0g, 3.0 mmol)were dissolved in 70 mL methanol. The solution was degassed for 15 minutes before refluxingfor 3 h under argon. The reaction was filtered while hot using a fine frit. The filtrate wasevaporated to near dryness under reduced pressure. The solid was then dissolved in small amountof methanol and precipitated twice in DEE (2 x 100 mL). The solid was dried to yield a lightyellow solid (1.7 g, yield 97%). 1H NMR (500MHz, RT, DMSO-d6): delta (ppm) 10.1 (2H, d, J =5.5 Hz), 8.16 (2H, d, J = 5.5 Hz), 8.12 (2H, s) 7.66-7.74 (10H, m) 6.36 (6H, s). UV-Vis inDMF: lambdamax. 294 nm, and a shoulder at 343 nm.

As the paragraph descriping shows that 1662-01-7 is playing an increasingly important role.

Reference£º
Article; Kosgei, Gilbert K.; Livshits, Maksim Y.; Canterbury, Theodore R.; Rack, Jeffery J.; Brewer, Karen J.; Inorganica Chimica Acta; vol. 454; (2017); p. 67 – 70;,
Metal catalyst and ligand design
Ligand Template Strategies for Catalyst Encapsulation – NCBI

With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.1662-01-7,4,7-Diphenyl-1,10-phenanthroline,as a common compound, the synthetic route is as follows.

General procedure: The precursors were synthesized according to a previously reportedmethod. A solution of [RuCl2(eta6-C10H14)]2 (0.200 g, 0.31 mmol) with an excess of the desired N-N ligand (0.75 mmol) in methanol (25 mL) was stirred for 1 h. NH4PF6 (0.30 g; 1.00 mmol) was added to this solution, also dissolved in methanol (5 mL), and the mixture was stirred at room temperature for 1 h longer. The orange-yellow solid that precipitated was filtered off, washed with cold methanol and diethyl ether, and dried under vacuum.

1662-01-7 4,7-Diphenyl-1,10-phenanthroline 72812, acatalyst-ligand compound, is more and more widely used in various.

Reference£º
Article; Colina-Vegas, Legna; Villarreal, Wilmer; Navarro, Maribel; De Oliveira, Clayton Rodrigues; Graminha, Angelica E.; Maia, Pedro Ivo Da S.; Deflon, Victor M.; Ferreira, Antonio G.; Cominetti, Marcia Regina; Batista, Alzir A.; Journal of Inorganic Biochemistry; vol. 153; (2015); p. 150 – 161;,
Metal catalyst and ligand design
Ligand Template Strategies for Catalyst Encapsulation – NCBI